Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
Just about every evening when I sit down for dinner and turn on the television, a series of commercials with catchy jingles grabs my attention. It’s always the same ads, each promoting a treatment from a pharmaceutical company. The most recognizable commercials at this point are